These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18378719)

  • 1. Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
    Miller K; O'Neill AJ; Wilcox MH; Ingham E; Chopra I
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1940-4. PubMed ID: 18378719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
    Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.
    Meka VG; Gold HS; Cooke A; Venkataraman L; Eliopoulos GM; Moellering RC; Jenkins SG
    J Antimicrob Chemother; 2004 Oct; 54(4):818-20. PubMed ID: 15347637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.
    Besier S; Ludwig A; Zander J; Brade V; Wichelhaus TA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1570-2. PubMed ID: 18212098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3.
    Locke JB; Morales G; Hilgers M; G C K; Rahawi S; José Picazo J; Shaw KJ; Stein JL
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5352-5. PubMed ID: 20837755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
    Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
    J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Zhu W; Tenover FC; Limor J; Lonsway D; Prince D; Dunne WM; Patel JB
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):161-5. PubMed ID: 17393201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
    Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
    J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones.
    Quiles-Melero I; García-Perea A; de Pablos M; Gómez-Gil R; Mingorance J
    Int J Med Microbiol; 2012 Jul; 302(3):145-7. PubMed ID: 22578666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis.
    Lobritz M; Hutton-Thomas R; Marshall S; Rice LB
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3318-20. PubMed ID: 14506047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
    Grohs P; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.
    Toh SM; Xiong L; Arias CA; Villegas MV; Lolans K; Quinn J; Mankin AS
    Mol Microbiol; 2007 Jun; 64(6):1506-14. PubMed ID: 17555436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations.
    Locke JB; Finn J; Hilgers M; Morales G; Rahawi S; G C K; Picazo JJ; Im W; Shaw KJ; Stein JL
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5337-43. PubMed ID: 20837751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio.
    Endimiani A; Blackford M; Dasenbrook EC; Reed MD; Bajaksouszian S; Hujer AM; Rudin SD; Hujer KM; Perreten V; Rice LB; Jacobs MR; Konstan MW; Bonomo RA
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1684-92. PubMed ID: 21263048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
    Mendes RE; Deshpande LM; Castanheira M; DiPersio J; Saubolle MA; Jones RN
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2244-6. PubMed ID: 18391032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain.
    Román F; Roldán C; Trincado P; Ballesteros C; Carazo C; Vindel A
    Antimicrob Agents Chemother; 2013 May; 57(5):2428-9. PubMed ID: 23459489
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
    Shaw KJ; Poppe S; Schaadt R; Brown-Driver V; Finn J; Pillar CM; Shinabarger D; Zurenko G
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4442-7. PubMed ID: 18838596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
    Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
    Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphyletic emergence of linezolid-resistant staphylococci in the United States.
    Wong A; Reddy SP; Smyth DS; Aguero-Rosenfeld ME; Sakoulas G; Robinson DA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):742-8. PubMed ID: 19933808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.